High-quality diagnostic and therapeutic solutions for patients, ethics as a guiding principle, dedication to innovation and progress, and a strong focus on people and environmental sustainability are among our core values.
The Menarini Group is conscious that the integration of environmental, social, and governance (ESG) criteria within its business model is essential in order to create sustainable value, and is thus committed to a structured sustainability approach.
The Menarini Group was founded in Italy in 1886, and has been headquartered in Florence since 1915. In 1964, Menarini developed its international presence with the launch of its subsidiaries in Europe and Central America. The Group further expanded its growth to include the USA, with the acquisition of Stemline (oncology) in 2020. The Menarini Group is now present in 140 countries around the world.